IMD-0560

• Description :

  IMD-0560 is a novel IκB kinase β inhibitor.

• UNSPSC :

  12352005

• Hazard Statement :

  H315, H319, H335

• Target :

  IKK

• Type :

  Reference compound

• Related Pathways :

  NF-κB

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/IMD-0560.html

• Purity :

  98.73

• Solubility :

  10 mM in DMSO|Ethanol : 50 mg/mL (ultrasonic)

• Smiles :

  O=C(C1=C(C=CC(Br)=C1)O)NC2=C(C=CC(C(F)(F)F)=C2)C(F)(F)F

• Molecular Formula :

  C15H8BrF6NO2

• Molecular Weight :

  428.12

• Precautions :

  H315, H319, H335

• References & Citations :

  [1]Tada Y, et al. The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma. Oncotarget. 2014 Dec 15;5 (23) :12317-30.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  IKK-β

• CAS Number :

  [439144-66-8]